DoD Reconstructive Transplant, Investigator Initiated Research Award | W81XWH 21 RTRP IIRA

Opportunity Information: Apply for W81XWH 21 RTRP IIRA

The FY21 DoD Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award (IIRA) is a Department of Defense funding opportunity designed to push forward reconstructive transplantation research in ways that can meaningfully improve patient care and quality of life. The intent is to support innovative, investigator-driven studies that could make a significant contribution to the field, while still requiring a strong scientific foundation and a clear line of sight to real-world usefulness. Even though the mechanism encourages groundbreaking ideas, proposals are expected to be well-justified, carefully planned, and tied to practical outcomes that matter to patients.

A major emphasis of the award is strong study design and feasibility. Applications are expected to lay out a clear, rigorous approach that is built for reproducibility and that has a realistic path toward translation. That means reviewers will be looking for well-defined objectives, appropriate methods, and thoughtful consideration of how the work could be replicated or extended. Where it fits the project, applicants should also include a statistical plan and a power analysis, demonstrating that the study is appropriately sized and structured to produce interpretable results rather than exploratory findings that cannot be confidently acted on.

Impact is another core requirement. Applicants need to explain both the short-term and long-term value of the proposed work, including how it could advance reconstructive transplant science, address barriers to care, improve functional outcomes, or otherwise influence clinical practice and patient well-being over time. Importantly, projects must align with at least one of the FY21 IIRA Focus Areas under the RTRP. In other words, it is not enough for a project to be interesting or novel; it must also be clearly responsive to the specific priorities the program has identified for that fiscal year.

Military relevance is required and is treated as a defining feature of the opportunity. Projects should be responsive to the health care needs of military Service Members and/or Veterans recovering from traumatic injuries, as well as potentially benefiting their families, caregivers, and clinicians. While collaboration with military researchers and clinicians is encouraged, it is not mandatory, but the proposal must still make a convincing case that the knowledge gained would be applicable to the populations and clinical challenges the DoD is focused on. This includes demonstrating how the research could address issues commonly encountered after traumatic injury and complex reconstruction, where reconstructive transplantation approaches may be relevant.

Preliminary data expectations are also spelled out. The program recognizes that early observations can come from many sources, including laboratory discoveries, population-based studies, clinical experience, and even anecdotal signals that inspire a research question. However, for most Focus Areas, applicants are expected to include preliminary and/or published data that directly support the rationale for the proposed work and demonstrate that the project is grounded in evidence and is ready for investment. The notable exception is the Focus Area titled "Retrospective studies of VCA" (vascularized composite allotransplantation), where the preliminary data requirement is treated differently, reflecting the nature of retrospective research.

In terms of what kinds of research are allowed, the IIRA is broad across the research pipeline, supporting basic through translational studies. This can include preclinical studies using animal models, research involving human subjects or human anatomical substances, and correlative studies that are tied to an existing clinical trial. What it does not allow is a clinical trial conducted under this award. The opportunity uses the standard definition of a clinical trial: any study in which one or more human subjects are prospectively assigned to one or more interventions (including placebo or controls) to evaluate effects on biomedical or behavioral health-related outcomes. So, applicants can do human-focused or clinically connected work, but they cannot run a prospective intervention trial under this specific mechanism.

Administratively, this is a discretionary DoD opportunity managed through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA). The funding opportunity number is W81XWH-21-RTRP-IIRA, and it supports awards through grants and cooperative agreements. Eligibility is listed as unrestricted, meaning it is open to a wide range of applicant organizations, subject to any additional eligibility details provided in the full announcement. The opportunity was created on August 4, 2021, with an original closing date of December 8, 2021. The listing noted an expectation of about seven awards, while the award ceiling was shown as 0 in the summary data, which typically signals that applicants need to rely on the full program announcement for budget limits or that the ceiling is not captured in the abbreviated record. The CFDA number associated with the program is 12.420, aligning it with DoD research and development assistance activities.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Reconstructive Transplant, Investigator Initiated Research Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Aug 04, 2021.
• Applicants must submit their applications by Dec 08, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 7 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 RTRP IIRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: